Phase III trial comparing UFT+PSK to UFT+LV in stage IIB, III colorectal cancer (MCSGO-CCTG)

Phase III trial comparing UFT+PSK to UFT+LV in stage IIB, III colorectal cancer (MCSGO-CCTG) Surg Today (2018) 48:66–72 https://doi.org/10.1007/s00595-017-1555-1 ORIGINAL ARTICLE Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO‑CCTG) 1 2 3 4 5 2 Yasuhiro Miyake · Junichi Nishimura · Takeshi Kato · Masataka Ikeda · Masaki Tsujie · Taishi Hata · 2 2 2 4 1 Ichiro Takemasa · Tsunekazu Mizushima · Hirofumi Yamamoto · Mitsugu Sekimoto · Riichiro Nezu · 2 2 Yuichiro Doki · Masaki Mori · Multi‑ center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO) Received: 21 December 2016 / Accepted: 22 May 2017 / Published online: 20 June 2017 © Springer Japan KK 2017 Abstract or UFT/LV (n = 179) (median age 65 years, colon/ Purpose Oral adjuvant uracil and tegafur plus leucovorin rectum 67.4/32.6%, stage IIB/IIIA/IIIB/IIIC (UFT/LV) is not inferior to standard weekly fluorouracil 11.1/15.7/55.0/18.2%). The 3-year DFS rate was 82.3% and folinate for stage II/III colon cancer. However, protein- in those receiving UFT/LV and 72.1% in those receiv- bound polysaccharide K (PSK) has been evaluated as post- ing UFT/PSK. The non-inferiority of UFT/PSK adjuvant operative adjuvant therapy for colorectal cancer. This report therapy to UFT/LV therapy was not verified ( −9.06%, 90% http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Surgery Today Springer Journals

Loading next page...
 
/lp/springer_journal/phase-iii-trial-comparing-uft-psk-to-uft-lv-in-stage-iib-iii-xbxNH0Z5Zp
Publisher
Springer Japan
Copyright
Copyright © 2017 by Springer Japan KK
Subject
Medicine & Public Health; Surgery; Surgical Oncology
ISSN
0941-1291
eISSN
1436-2813
D.O.I.
10.1007/s00595-017-1555-1
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial